Cerner isn't the only EHR vendor looking to expand its reach as the industry continues to talk about the move to value.
The Food and Drug Administration is forming a task force to find ways to improve the supply of crucial drugs. It's a new approach for the drug regulator, which has no control over companies.
Abbott Laboratories needs to decide whether to jump back into the merger arena or rely on internal revenue sources to drive growth and support Abbott's shares, which have leveled off since climbing 40% to a five-year peak of $63.62 during the 12 months ended in March.
While some proton therapy centers across the country have reportedly struggled to stay profitable, officials at University Hospitals in Cleveland say they've found the "sweet spot" two years after the health system opened its own $30 million center.